Systemic Lupus erythematosus: Biological Effects of Iberdomide

被引：0
|
作者：
Brudermanns, Britta
机构：
来源：
AKTUELLE RHEUMATOLOGIE | 2023年 / 48卷 / 02期
关键词：
D O I：
10.1055/a-1950-2783
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Systemischen Lupus erythematodes (SLE) wird durch Gene der Immunresponse-Signalwege und dem Major Histocompatibility Complex Klasse I und II beeinflusst. Iberdomid ist ein hochaffiner Cereblon-Ligand, der den proteasomalen Abbau der Transkriptionsfaktoren Ikaros (IKZF1) und Aiolos (IKZF3) fordert. P. E. Lipsky und Kollegen untersuchten nun die Pharmakodynamik und Pharmakokinetik von oral verabreichtem Iberdomid bei Patienten mit SLE.
引用
收藏
页码：100 / 100
页数：1
相关论文
共 50 条
  • [11] Emerging biological therapies for systemic lupus erythematosus
    Mok, Chi Chiu
    EXPERT OPINION ON EMERGING DRUGS, 2014, 19 (02) : 303 - 322
  • [12] Effect of iberdomide on cutaneous manifestations in systemic lupus erythematosus: A randomized phase 2 clinical trial
    Werth, Victoria P.
    Merrill, Joan T.
    Furie, Richard
    Dorner, Thomas
    van Vollenhoven, Ronald
    Lipsky, Peter
    Weiswasser, Michael
    Korish, Shimon
    Schafer, Peter H.
    Stern, Mark
    Li, Stan
    Delev, Nikolay
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2025, 92 (03) : 435 - 443
  • [13] Research on biological therapies in systemic lupus erythematosus
    Cervera, Ricard
    MEDICINA CLINICA, 2017, 148 (02): : 67 - 68
  • [14] Upcoming biological therapies in systemic lupus erythematosus
    Sciascia, Savino
    Talavera-Garcia, Eva
    Roccatello, Dario
    Baldovino, Simone
    Mengatti, Elisa
    Cuadrado, Maria Jose
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2015, 27 (02) : 189 - 193
  • [15] An era of biological treatment in systemic lupus erythematosus
    Jing He
    Zhanguo Li
    Clinical Rheumatology, 2018, 37 : 1 - 3
  • [16] An era of biological treatment in systemic lupus erythematosus
    He, Jing
    Li, Zhanguo
    CLINICAL RHEUMATOLOGY, 2018, 37 (01) : 1 - 3
  • [17] BIOLOGICAL DIAGNOSIS OF SYSTEMIC LUPUS-ERYTHEMATOSUS
    LESAVRE, P
    BACH, JF
    REVUE DE MEDECINE, 1980, 21 (17): : 877 - 880
  • [18] The first biological approved to treat systemic lupus erythematosus
    Fiehn, Christoph
    IMMUNOTHERAPY, 2011, 3 (11) : 1293 - 1294
  • [19] Approach to vaccination in systemic lupus erythematosus on biological treatment
    Yildirim, Resit
    Oliveira, Tatiana
    Isenberg, David Alan
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (09) : 1123 - 1129
  • [20] Systemic lupus erythematosus, discoid lupus erythematosus, and progressive systemic sclerosis
    Foster, CS
    INTERNATIONAL OPHTHALMOLOGY CLINICS, 1997, 37 (02) : 93 - 110
12345